The IIFL Securities Report: Buy Medi Assist Health Ser L - January 08
Best Stock to Buy Today : IIFL Securities has buy call on Medi Assist Health Ser L with a target price of Rs 700. The current market price of Medi Assist Health Ser L is Rs 607.05.
IIFL Securities recommends buying Medi Assist Health Services Limited (Medi Assist) shares, targeting a price of Rs 700. The stock is currently trading at Rs 607.05. Medi Assist is a leading health insurance TPA (Third Party Administrator) in India, providing services to over 100 health insurance companies and servicing over 70 million lives. The company's strong market position, focus on digitalization, and expanding product portfolio are expected to drive future growth. With a positive outlook on the company's prospects, IIFL Securities recommends investors consider buying Medi Assist shares for potential returns.
About Medi Assist Health Ser L:
Medi Assist Health Services Ltd., listed on the National Stock Exchange (NSE), is a leading third-party administrator (TPA) in India, providing comprehensive health insurance services to corporations, individuals, and government entities. The company offers a wide range of products and services, including health insurance claim processing, wellness programs, and preventive healthcare initiatives. With a vast network of healthcare providers and a state-of-the-art technology platform, Medi Assist aims to provide seamless and efficient healthcare solutions to its customers.
52 Week Price Trend:
Medi Assist Health Services Ltd. (MEDIASSIST) is currently trading at Rs 607.05, which falls within its 52-week price range of Rs 430.15 and Rs 716.15. The stock has experienced significant volatility over the past year, with its price fluctuating between these extremes. Given its current position, investors may want to consider evaluating the company's financial performance, market conditions, and future prospects before making any investment decisions.
Stratzy's MOST Analysis:
MEDIASSIST's BBB rating from Stratzy's MOST framework indicates a medium fundamental risk. This rating is derived from an assessment of the company's Management, Outlook, Safety, and Trend. The framework assigns scores to each pillar, and the overall score is then used to determine the final rating. A BBB rating suggests that MEDIASSIST has some areas of strength, but also some weaknesses that investors should be aware of before making any investment decisions.
Company's Fundamentals:
Medi Assist Health Ser L (NSE:MEDIASSIST) is a healthcare company listed on the National Stock Exchange (NSE) of India. As of the current market valuation, the stock trades at a price-to-earnings (PE) ratio of 49.04, indicating that investors are willing to pay approximately 49 times the company's annual earnings for each share. The price-to-book (PB) ratio of 8.6 suggests that the stock is priced at 8.6 times its book value, a measure of the company's net assets. Despite the relatively high valuations, Medi Assist Health Ser L offers a dividend yield of 0.67%, providing investors with a modest return on their investment in addition to potential capital appreciation.
Fundamental and Technical information provided in this blog were last updated on 08 Jan, 2025
Disclaimer: The information and recommendations presented in this section, including any attached reports, are sourced from third-party providers through diverse channels. The views and opinions expressed within these materials belong solely to their respective creators. These views and opinions do not necessarily reflect the position of Stratzy Fintech Pvt Ltd. Stratzy explicitly disclaims any guarantees, express or implied, regarding the accuracy and reliability of the provided content. We strongly advise consulting with a licensed financial advisor before making any investment decisions based on this information. Remember, seeking independent financial advice is crucial.